Key facts
- It has raised $1.8M; the latest was Later Stage VC ($1.8M) in Oct 2025.
- Notable investors include Tech Incubator Program for Startup, IBK Changgong, Korea Credit Guarantee Fund, D-Camp, Capstone Partners Korea — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for TR Corporation
- ·The full record, as it builds
Funding rounds
No funding rounds for TR Corporation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TR Corporation
Operator of a smart healthcare and medical technology company intended for early disease detection and therapeutic support. The company offers artificial intelligence-based respiratory disease testing, compression bands for musculoskeletal stability, and an Internet of Things-enabled nebulizer for hygienic drug delivery, integrating advanced diagnostics, wearable medical solutions, and automated treatment systems, enabling healthcare professionals and patients to improve disease management, enhance accessibility to medical care, and optimize treatment outcomes.
- Sector
- Healthcare
- HQ
- Daejeon, South Korea
- Founded
- 2018
- Employees
- 23
- Website
- theresearcher.co.kr/
- Ownership
- Privately Held (backing)
TR Corporation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TR Corporation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TR Corporation in its N-PORT filings yet. We sweep new filings monthly.